Literature DB >> 34050448

A threshold concentration of FSH is needed during IVM of ex vivo collected human oocytes.

Jesús Cadenas1, Dmitry Nikiforov2, Susanne Elisabeth Pors2, Lenin Arturo Zuniga2, Yu Wakimoto2,3, Zeinab Ghezelayagh2,4, Linn Salto Mamsen2, Stine Gry Kristensen2, Claus Yding Andersen2.   

Abstract

PURPOSE: To investigate the effect of different FSH concentrations on human oocyte maturation in vitro and its impact on gene expression of key factors in the surrounding cumulus cells.
METHODS: The study included 32 patients who underwent unilateral oophorectomy for ovarian tissue cryopreservation (OTC) (aged 28 years on average). Immature oocytes were collected from surplus medulla tissue. A total of 587 immature oocytes were divided into three categories according to the size of the cumulus mass: large (L-COCs), small (S-COCs), and naked oocytes (NOs), and submitted to 44-h IVM with one of the following concentrations of recombinant FSH: 0 IU/L, 20 IU/L, 40 IU/L, 70 IU/L, or 250 IU/L. After IVM, oocyte nuclear maturation stage and diameter were recorded. The relative gene expression of FSHR, LHCGR, and CYP19A1 in cumulus cells before (day 0; D0) and after IVM were evaluated.
RESULTS: Addition of 70 or 250 IU/L FSH to the IVM medium improved oocyte nuclear maturation compared to 0, 20, and 40 IU/L FSH by upregulating LHCGR and downregulating FSHR in the cumulus cells.
CONCLUSION: FSH improved oocyte nuclear maturation at concentrations above 70 IU/L suggesting a threshold for FSH during IVM of ex vivo collected human oocytes from small antral follicles. Moreover, current results for the first time highlight that FSH function in vitro is mediated via cumulus cells by downregulating FSHR and upregulating LHCGR, which was also observed when the immature oocytes progressed in meiosis from the GV to the MII stage.

Entities:  

Keywords:  Ex vivo collected oocytes; FSH; Fertility preservation; IVM; Small antral follicles

Mesh:

Substances:

Year:  2021        PMID: 34050448      PMCID: PMC8266958          DOI: 10.1007/s10815-021-02244-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  36 in total

Review 1.  In vivo and in vitro effects of FSH on oocyte maturation and developmental competence.

Authors:  M-A Sirard; S Desrosier; M Assidi
Journal:  Theriogenology       Date:  2007-06-22       Impact factor: 2.740

2.  Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years.

Authors:  Peter S Uzelac; Abigail A Delaney; Greg L Christensen; Henry C L Bohler; Steven T Nakajima
Journal:  Fertil Steril       Date:  2015-08-18       Impact factor: 7.329

3.  Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome.

Authors:  Michel De Vos; Carolina Ortega-Hrepich; Firas K Albuz; Luis Guzman; Nikolaos P Polyzos; Johan Smitz; Paul Devroey
Journal:  Fertil Steril       Date:  2011-08-24       Impact factor: 7.329

Review 4.  FERTILITY PRESERVATION: Freezing of ovarian tissue and clinical opportunities.

Authors:  C Yding Andersen; L S Mamsen; S G Kristensen
Journal:  Reproduction       Date:  2019-11       Impact factor: 3.906

5.  In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience.

Authors:  A Le Du; I J Kadoch; N Bourcigaux; S Doumerc; M-C Bourrier; N Chevalier; R Fanchin; R-C Chian; G Tachdjian; R Frydman; N Frydman
Journal:  Hum Reprod       Date:  2004-11-04       Impact factor: 6.918

6.  In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes.

Authors:  M L Walls; T Hunter; J P Ryan; J A Keelan; E Nathan; R J Hart
Journal:  Hum Reprod       Date:  2014-10-29       Impact factor: 6.918

7.  First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient.

Authors:  E B Prasath; M L H Chan; W H W Wong; C J W Lim; M D Tharmalingam; M Hendricks; S F Loh; Y N Chia
Journal:  Hum Reprod       Date:  2013-12-09       Impact factor: 6.918

8.  Spontaneous in vitro maturation of oocytes prior to ovarian tissue cryopreservation in natural cycles of oncologic patients.

Authors:  María-José Escribá; Noelia Grau; Laura Escrich; Edurne Novella-Maestre; María Sánchez-Serrano
Journal:  J Assist Reprod Genet       Date:  2012-09-11       Impact factor: 3.412

9.  Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome.

Authors:  Stephen M Junk; Doreen Yeap
Journal:  Fertil Steril       Date:  2012-07-24       Impact factor: 7.329

10.  Hallmarks of Human Small Antral Follicle Development: Implications for Regulation of Ovarian Steroidogenesis and Selection of the Dominant Follicle.

Authors:  Stine G Kristensen; Linn S Mamsen; Janni V Jeppesen; Jane Alrø Bøtkjær; Susanne E Pors; Tanni Borgbo; Erik Ernst; Kirsten T Macklon; Claus Yding Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-12       Impact factor: 5.555

View more
  4 in total

Review 1.  A synopsis of the 2021 International Society of Fertility Preservation bi-annual meeting.

Authors:  Luciana Cacciottola; Marie-Madeleine Dolmans; Glenn L Schattman
Journal:  J Assist Reprod Genet       Date:  2022-07-18       Impact factor: 3.357

2.  Clinical Outcomes of In Vitro Maturation After Oocyte Retrieval With Gynecological Surgery for Refractory Polycystic Ovary Syndrome: A Retrospective Cohort Study.

Authors:  Wen Zhang; Tingting Liang; Bing Han; Rui Yang; Shuo Yang; Yan Yang; Jiajia Zhang; Xiaoying Zheng; Jie Yan; Caihong Ma; Xueling Song; Jie Qiao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-04       Impact factor: 5.555

3.  Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM.

Authors:  Jesús Cadenas; Susanne Elisabeth Pors; Ajay Kumar; Bhanu Kalra; Stine Gry Kristensen; Claus Yding Andersen; Linn Salto Mamsen
Journal:  Reprod Biol Endocrinol       Date:  2022-08-19       Impact factor: 4.982

4.  Validating Reference Gene Expression Stability in Human Ovarian Follicles, Oocytes, Cumulus Cells, Ovarian Medulla, and Ovarian Cortex Tissue.

Authors:  Jesús Cadenas; Susanne Elisabeth Pors; Dmitry Nikiforov; Mengxue Zheng; Cristina Subiran; Jane Alrø Bøtkjær; Linn Salto Mamsen; Stine Gry Kristensen; Claus Yding Andersen
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.